A carregar...
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity
The immunosuppressive tumor microenvironment (TME) is a formidable barrier to the success of adoptive cell therapies for solid tumors. Oncolytic immunotherapy with engineered adenoviruses (OAd) may disrupt the TME by infecting tumor cells, as well as surrounding stroma, to improve the functionality...
Na minha lista:
| Publicado no: | Mol Ther |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Gene & Cell Therapy
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8116608/ https://ncbi.nlm.nih.gov/pubmed/33571680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2021.02.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|